# Jiangxi Shantai Health Industry Development Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangxi-shantai-health-industry-development-co

- Industry: Biotechnology
- Headquarters: Nanchang, China
- Website: www.shanxingshengwu.com
- Latest round: Series A (Aug 8, 2022)
- Investors on record: 1

## About

Based in China, and founded in 2018, Jiangxi Shantai Health Industry Development Co., Ltd. develops microecological and immune-related medical technologies. The company was founded by Wang Jingsu. In August 2022, Jiangxi Shantai Health Industry Development Co., Ltd. raised series A funding from Huihong Capital.

The company’s product line includes HPV virus removal products, probiotic products, and intestinal flora products. It provides patients with better treatment by developing medicinal technologies related to immunity and microecology, such as centenarian probiotics, tumor immunotherapy, anti-aging management, and immune function management.

The company plans to use the funds raised in August 2022 for clinical research of enterobacterial transplantation in tumors, autism, and infection diseases; microecological drug pipeline development; team and market channel construction; and building an industrial innovation service platform with immune microecological technology as the core.

## Funding rounds

- Series A, Aug 8, 2022 — Huihong Capital

## Investors

- Huihong Capital (https://capitalatlas.ai/funds/huihong-capital) — Series A